I think the higher than expected cash at end of quarter is due to a tax rebate rather than the performance of the infusion business. Otherwise the numbers don't add up considering the growth rates of the infusion business. We will know in a few days.
Ann: Investor presentation, page-57
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.71 |
Change
-0.290(1.61%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.71 | $16.28K | 902 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 336 | $17.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.06 | 18 | 3 |
View Market Depth
| Last trade - 11.55am 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |